Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

BUTTON 1 - Helpline.png

BUTTON 2 - new pathways.png


While analysing trends in occupational deaths in England and Wales, researchers noticed an unexpected elevated proportion of mortality rates as a result of multiple sclerosis (MS) among men in the...

Scientists have identified the elementary function of the protein, Caveolin-1 in the plasma membrane of B-cells, which prevents the development of autoimmune conditions.

B-cells, the immune...

Researchers who set out to determine the association between dietary factors and MS in children have found that they consume less iron.

The study,...

According to a study conducted at the Mayo Clinic in America, a human gut bacteria discovered by researchers may help treat autoimmune diseases such as multiple sclerosis (MS).

The Mayo...

Patricia Gachagan, author and MSer is launching a new radio show on the MS and Me Radio Network.

Created by Multiple Sclerosis Global Support Network (MSGSN), MS and Me is a new global...

A study of RRMS patients, treated with natalizumab, reported improvements in physical and psychological health-related quality of life and treatment satisfaction.

The improvements were...

New research has revealed that resistance training protects the brains of people with multiple sclerosis (MS), which may delay the development of the disease. ...

Analysis of clinical trials does not show a significant association between depression and beta-interferon (IFNβ) treatment in multiple sclerosis (MS).

MS is considered as a considerable...

The US Food and Drug Administration (FDA) has given Q Therapeutics, developer of clinical-stage cell therapies for central system disease and injury, the go ahead on a...

The current focus for the treatment of multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. As a result, healthcare costs have shifted...

Pages

Live Chat Software by Click4Assistance UK